| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/19/2006 | EP1681304A2 Recombinant fusion proteins of growth hormone and serum albumin |
| 07/19/2006 | EP1681302A1 Novel protein and production process and use thereof |
| 07/19/2006 | EP1680507A2 Bacterial expression of protease inhibitors and variants thereof |
| 07/19/2006 | EP1680502A2 Recombinant microorganism |
| 07/19/2006 | EP1680500A2 High temperature and alkaline stable catalase |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1076566B1 Attenuated mutants of salmonella which constitutively express the vi antigen |
| 07/19/2006 | EP0835447B1 Novel peptides and compositions which modulate apoptosis |
| 07/19/2006 | EP0690724B1 Chlamydia vaccine comrising anti-idiotypic antibodies |
| 07/19/2006 | CN1806040A Extract from cultured mammalian cell, process for preparation thereof and method of cell-free protein synthesis using the extract |
| 07/19/2006 | CN1803843A Monoclonal antibody ZUF10 of human bone marrow mesenchymal stem cells and application |
| 07/19/2006 | CN1803828A Method for extracting protein from paraffin-embedded tissue |
| 07/19/2006 | CN1264980C Novel tumor antigen protein SART-3 and tumor antigen peptide thereof |
| 07/19/2006 | CN1264861C Receptor targeting chimeric toxin with junctional sequence |
| 07/19/2006 | CN1264860C Method for surface display of proteins on genetic carriers |
| 07/19/2006 | CN1264573C Method for preparing targeting preparation of human monoclonal antibody crosslinking interferon for anti hepatitis b virus |
| 07/19/2006 | CN1264572C Fusion protein for treating HBV and its uses |
| 07/19/2006 | CN1264568C Virulence genes and proteins, and their use |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078511 nucleic acid molecule encoding Hamster scavenger receptor BI (HaSR-BI) which has high affinity for low density lipoproteins (LDL) and acylated LDL, expressed in adipocytes; antilipemic, anticholesterol agents; receptor binding assay; drug screening |
| 07/18/2006 | US7078506 Canineil-4nucleic acid molecules and uses thereof |
| 07/18/2006 | US7078504 Enzymes having dehalogenase activity and methods of use thereof |
| 07/18/2006 | US7078495 minimal cross reactivity with tacolimus metaolites; antibody is conjugated with a detectable label; sample reacted with an enzyme labelled tacrolimus analogue, total signal present is measured; test kits |
| 07/18/2006 | US7078492 Human antipneumococcal antibodies from non-human animals |
| 07/18/2006 | US7078491 Selective binding agents of telomerase |
| 07/18/2006 | US7078488 Temperature-stable glycosylated recombinant chicken cystatin and the use thereof |
| 07/18/2006 | US7078487 Polynucleotides encoding the zebrafish PTH1R (parthyroid hormone like protein) receptor |
| 07/18/2006 | US7078486 Single-chain polypeptides comprising troponin I and troponin C |
| 07/18/2006 | US7078485 Endostatin proteins with metal chelate compounds with peptide sequences for treating angiogenesis diseases and reduction |
| 07/18/2006 | US7078223 Preparation of pseudomonic acid A; obtain bacteria capable of producing pseudomonic acid A, culture, ferment and isolate pseudomonic acid A from culture |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078211 Nucleic acid molecules encoding endonucleases and methods of use thereof |
| 07/18/2006 | US7078207 Polypeptides having β-1,4-GalNAc transferase activity |
| 07/18/2006 | US7078204 Glucose-6-phosphate dehydrogenase |
| 07/18/2006 | US7078203 Polynucleotide sequences; complementary antibodies; screening active materials capable of binding and interference with binding; genetic engineering |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078193 Pathogenic Escherichia coli associated protein espA |
| 07/18/2006 | US7078192 Method for immobilization of polypeptides |
| 07/18/2006 | US7078191 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 07/18/2006 | US7078190 Expression vector comprising saccharomyces regulatory sequences for controlling heterologous and homologous gene expression; genetic engineering protein translation |
| 07/18/2006 | US7078189 Preparing recombinant g protein coupled receptor in baculoviral/insect cell systems for generating models of receptor/ligand binding interactions; identifying modulators of membrane protein activity |
| 07/18/2006 | US7078188 Diagnosis of pancrea cancer |
| 07/18/2006 | US7078186 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of tumor disorders |
| 07/18/2006 | US7078185 Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin |
| 07/18/2006 | US7078179 High speed detection, isolation of cells; binding to antibodies; fluorescence classification; purification of antibody from egg yolk |
| 07/18/2006 | US7078175 Antibodies for apoptosis EI24 protein and methods of use |
| 07/18/2006 | US7078166 Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries |
| 07/18/2006 | US7078041 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 07/18/2006 | US7078036 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 07/18/2006 | US7078032 Delivery of therapeutic biologicals from implantable tissue matrices |
| 07/18/2006 | CA2307317C Tumor rejection antigen precursors, tumor rejecti0n antigens and uses thereof |
| 07/18/2006 | CA2195556C Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 07/18/2006 | CA2194135C Recombinant mono and poly antigens to detect cytomegalovirus-specific igm in human sera by enzyme immunoassay |
| 07/18/2006 | CA2175068C The recombinant production of proteins in yeast |
| 07/13/2006 | WO2006074409A1 Tripeptide and tetrapeptide sulfones |
| 07/13/2006 | WO2006074249A1 Tripeptide and tetrapeptide thioethers |
| 07/13/2006 | WO2006074199A1 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/13/2006 | WO2006073976A2 Compositions, methods, and kits for enhancing protein expression, solubility and isolation |
| 07/13/2006 | WO2006073892A2 Phi 15 dna polymerase |
| 07/13/2006 | WO2006073422A2 Activation of natural killer (nk) cells and methods of use |
| 07/13/2006 | WO2006073417A2 Prophylactic and therapeutic uses of fgf-20 in radiation protection |
| 07/13/2006 | WO2006073320A1 A ubp1 protease mutant,and its coding sequence, their applications and heterogonous protein expression system |
| 07/13/2006 | WO2006073151A1 Novel fermentation product |
| 07/13/2006 | WO2006073133A1 Novel tannase gene and protein thereof |
| 07/13/2006 | WO2006073070A1 Cell culture method and utilization of the same |
| 07/13/2006 | WO2006044459A3 Prion protein binding materials and methods of use |
| 07/13/2006 | WO2005081749A3 Neutralizing human antibodies to anthraxtoxin |
| 07/13/2006 | WO2005069845A3 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 07/13/2006 | WO2005032454A3 Anti-muc-1 single chain antibodies for tumor targeting |
| 07/13/2006 | WO2004060300A3 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| 07/13/2006 | WO2003095621A3 Apoptotic ebv-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferactive disorder |
| 07/13/2006 | US20060156427 Structure-based designed herbicide resistant products |
| 07/13/2006 | US20060156423 Method of screening antiobesity agents and animal model of obesity |
| 07/13/2006 | US20060155118 Affinity purification system using troponin molecules as affinity ligands |
| 07/13/2006 | US20060155117 Novel preadipocyte factor-1-like polypeptides |
| 07/13/2006 | US20060155115 Multivalent T cell receptor complexes |
| 07/13/2006 | US20060155113 Replication protein |
| 07/13/2006 | US20060155111 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 07/13/2006 | US20060154859 Leptin antagonists |
| 07/13/2006 | US20060154858 Canine rankl and methods for preparing and using the same |
| 07/13/2006 | US20060154844 Use of endoglucanase 6 in saccharification of biomass; fermenation to ethanol |
| 07/13/2006 | US20060154843 Neutral cellulase catalytic core and method of producing same |
| 07/13/2006 | US20060154842 Lipoxygenase |
| 07/13/2006 | US20060154348 Process for producing HMG-CoA reductase inhibitors |
| 07/13/2006 | US20060154342 Acid fungal proteases |
| 07/13/2006 | US20060154340 Expression of potato proteinase inhibitor II in microbial hosts |
| 07/13/2006 | US20060154339 Novel clock gene BMAL2 |
| 07/13/2006 | US20060154338 Novel antibiotic alternatives |
| 07/13/2006 | US20060154337 Gene encoding chondroitinase ABC and uses therefor |
| 07/13/2006 | US20060154336 Nucleic acid molecules for optimized CAB-2 expression and their use |
| 07/13/2006 | US20060154335 Novel members of the steroid/thyroid superfamily and uses therefor |
| 07/13/2006 | US20060154334 Method of producing an antibody to epidermal growth factor receptor |
| 07/13/2006 | US20060154333 Pan-HER antagonists and methods of use |
| 07/13/2006 | US20060154332 Selective capture and enrichment of proteins expressed on the cell surface |
| 07/13/2006 | US20060154331 Erythrocyte differentiation factor, gene encoding same, and methods of use thereof |
| 07/13/2006 | US20060154330 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 07/13/2006 | US20060154329 Expression system |
| 07/13/2006 | US20060154323 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes |
| 07/13/2006 | US20060154318 Stable isotope labeled polypeptide standards for protein quantitation |
| 07/13/2006 | US20060154313 Human B7 polypeptide B7-H3A |